Fulcrum therapeutics appoints patrick horn m.d., ph.d., as chief medical officer

―industry veteran with late-stage clinical development, medical affairs, and regulatory experience; well-positioned to advance losmapimod towards a potential regulatory submission and approval ―
FULC Ratings Summary
FULC Quant Ranking